About this trial
The goal of this registry is collecting data of severe asthma patients, recruited by specialized centers, in a real life setting, homogeneously placed on a database management system to follow them over the time.
The information recorded will provide:
1. The collection of homogeneous clinical, functional and biologic data of patients with severe asthma in a real life setting. 2. The evaluation of adherence to treatment in real life. 3. The clinical eligibility of patients treated with biologics. 4. The evaluation of patients' clinical response to each treatment. 5. The monitoring of tolerability and safety. 6. The long-term follow up of patients with severe asthma.
Eligibility criteria
Qualifiers
signed informed consent and privacy disclaimer;
age > 12 years;
High-dose ICS + at least one addistional controller (LABA, montelukast, or theophylline) or
Oral corticosteroids >6 months/year
Disqualifiers
None
Trial design
Treatments tested in this trial
- Not listed
Trial groups
Sponsors and collaborators
Società Italiana di Allergologia, Asma e Immunologia Clinica
Lead sponsor
Societa Italiana di Pneumologia
Collaborator